- Release Date: 13/07/20 09:51
- Summary: Final Approvals Received to Commence Clinical Study
- Price Sensitive: Yes
- Download Document 120.44KB
- Forums
- ASX - By Stock
- Ann: Final Approvals Received to Commence Clinical Study
HMD
heramed limited
Add to My Watchlist
0.00%
!
3.4¢

Ann: Final Approvals Received to Commence Clinical Study
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.39M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 99999 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 99999 | 0.036 |
1 | 1000000 | 0.035 |
4 | 2088107 | 0.034 |
1 | 1000000 | 0.033 |
2 | 2000000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 100000 | 1 |
0.036 | 70000 | 1 |
0.037 | 695306 | 2 |
0.038 | 155000 | 2 |
0.039 | 333333 | 1 |
Last trade - 08.42am 16/09/2025 (20 minute delay) ? |
Featured News
HMD (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman and CEO
Hank Holland
Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online